WHOOP Expands Women’s Health Offerings with Specialized Blood Biomarker Panel
Event summary
- WHOOP to launch Women’s Health Specialized Blood Biomarker Panel in April 2026, adding 11 female-specific biomarkers.
- Women represent 150% year-over-year growth in WHOOP membership, with 30% higher engagement with WHOOP AI than male members.
- New Hormonal Symptom Insights and Predictions update integrates with WHOOP Advanced Labs for personalized biomarker ranges.
- WHOOP publishes Menstrual Cycle White Paper detailing research and methodology behind its cycle modeling.
The big picture
WHOOP’s expansion into women’s health reflects a broader industry trend towards personalized health solutions that account for hormonal dynamics and long-term health outcomes. The company’s focus on continuous monitoring and AI-driven insights positions it to close long-standing data gaps in women’s health, potentially setting a new standard for health tech platforms. With a growing user base and increasing engagement, WHOOP is well-positioned to capitalize on the rising demand for comprehensive health insights.
What we're watching
- Market Expansion
- Whether WHOOP can sustain its 150% year-over-year growth in women members with the new specialized offerings.
- Data Integration
- How the integration of continuous wearable metrics and AI modeling will enhance the accuracy of hormonal predictions.
- Regulatory Compliance
- The pace at which WHOOP can expand the Women’s Health Specialized Panel beyond the US, given regulatory constraints.
Related topics